Skip to main content
Equibles

683 Capital Management, LLC

Position in IFRX — InflaRx N.V.

CIK 1404574 NEW YORK, NY
Back to IFRX Full portfolio

Position in IFRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,345,600
+$8,381,990 QoQ
Shares Held
5,065,000
+52.8% QoQ
Ownership
3.44%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#6
of 62 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IFRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

683 Capital Management, LLC holds $349,034,024 across 34 Biotechnology names. IFRX ranks #11 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ANAB
Anaptysbio, Inc
 660,000 $44,550,000
2 PTGX
Protagonist Therapeutics, Inc
 290,000 $35,548,200
3 MGTX
MeiraGTx Holdings plc
 2,300,000 $31,073,000
4 WVE
Wave Life Sciences, Inc.
 4,950,000 $28,759,500
5 QURE
uniQure N.V.
 575,000 $26,484,500
6 TGTX
Tg Therapeutics, Inc.
 389,081 $21,376,110
7 PHAT
Phathom Pharmaceuticals, Inc.
 1,850,000 $20,072,500
8 TRAX
First Tracks Biotherapeutics, Inc.
 750,000 $15,090,000

All Filings in IFRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,345,600 5,065,000
2026-03-31 $2,963,610 3,315,000
2025-12-31 $3,348,150 3,315,000
2025-09-30 $3,015,000 2,250,000
2025-06-30 $1,955,250 2,475,000
2025-03-31 $2,677,500 2,625,000
2024-12-31 $5,112,900 2,070,000
2024-09-30 $3,167,100 2,070,000
2024-06-30 $3,601,800 2,070,000
2024-03-31 $1,339,800 870,000
2023-12-31 $1,418,100 870,000
2023-09-30 $7,003,000 2,350,000
2023-06-30 $8,920,000 2,000,000